Contribution to Clostridium Difficile Transmission of Symptomatic Patients With Toxigenic Strains Who Are Fecal Toxin Negative-Reference-Cited by-同舟云学术

Contribution to Clostridium Difficile Transmission of Symptomatic Patients With Toxigenic Strains Who Are Fecal Toxin Negative

Published:2017-02-03 Issue:9 Volume:64 Page:1163-1170
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Mawer Damian P. C.¹,Eyre David W.²³,Griffiths David²³,Fawley Warren N.¹⁴,Martin Jessica S. H.⁵,Quan T. Phuong²³,Peto Timothy E. A.²³,Crook Derrick W.²³⁶,Walker A. Sarah²³,Wilcox Mark H.¹⁵

Affiliation:

1. Department of Microbiology, Leeds Teaching Hospitals NHS Trust;

2. Nuffield Department of Medicine, University of Oxford;

3. National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford;

4. Leeds Regional Microbiology Laboratory, Public Health England;

5. Leeds Institute of Biomedical and Clinical Sciences, University of Leeds; and

6. Public Health England, Colindale, United Kingdom

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/64/9/1163/24254699/cix079.pdf

Reference28 articles.

1. Diverse sources of C. difficile infection identified on whole-genome sequencing;Eyre;N Engl J Med,2013

2. Genome-based infection tracking reveals dynamics of Clostridium difficile transmission and disease recurrence;Kumar;Clin Infect Dis,2015

3. Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing;Walker;PLoS Med,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving Clostridioides difficile Infectious Disease Treatment Response via Adherence to Clinical Practice Guidelines;Antibiotics;2024-01-04

2. Comparative Genomics of Clostridioides difficile;Advances in Experimental Medicine and Biology;2024

3. Prevalence of diagnostically-discrepant Clostridioides difficile clinical specimens: insights from longitudinal surveillance;Frontiers in Medicine;2023-10-18

4. Prevalence and risk factors of toxigenic Clostridioides difficile asymptomatic carriage in 11 French hospitals;Frontiers in Medicine;2023-07-19

5. A local-scale One Health genomic surveillance of Clostridioides difficile demonstrates highly related strains from humans, canines, and the environment;Microbial Genomics;2023-06-22